I mplantable cardioverter defibri lI ators (ICOs) are established as the optim al approach to prevent sudden cardiac death due to malignant entriclliar arrhythmias. 1 -.l And cardia reo ynchron izati on therapy combined with ICD (CRTD) h a~ been indicated in patients with adva nced heart fail ure a~ sociated wiLh electrical and/or mechanical dyssynchmny.+-7 At the time of implantation . an ICD genera ll y has to be teo ted to en lire that it can re liably sen. e ventricular fibrillation (VF) and deLi ver a direct-curren t shock wi th an acceptable safety margin to tenninate Lhe VF once or twice. This test. however. require~ repetitive VF induction and thus h~ potentially life-t hreateni ng complicati ons.8-lI Therefore. dcfibrilla tion testin g wi th minima! ri~k i ' req uired.
The upper limi t of vul nerabi lity (U L V) i. the weak~ t shock strengt h at whi ch VF ca n no longer be induced when a shock i. delivered during the cardiac vulnerable period. A close correlati on between the ULV and th e defibri llation threshold (OFT) has been va lidated in some studi es of humans and other animal s. 1 2-1~ and the safety and reliability of ICD implantation and programming of the lower first -shock streng th using vulnerability testing wit hou t F induction a. a surrogate for 01-1
as. essment has been demon ·trated . I 5--21
The present study eval uated Lhe usefulness of vu lner..lbili ty testing to confirm acceptab le DFT at the time of ICD implantati on and to predict high OFT (>20J). Optimal stren gth and number of shocks at LV testin g to predict high DFT wi thout inducing VF were assessed .
Re cived J a nu~ry 29. 20 t 3: re i~ed manu. eript received Ma 8. 20 13 Figure. Protocol for vulnerability and defibrillatIOn test, and patient flow. (#1 ) The vulnerability testing was started at 10J in the early enrolled 49 patients. VF was induced at 10J in 26 patients (53%; ULV > 10J) and not induced in 23 (47%; ULV S10J). Among the 26 patients in whom VF was induced at 10-J ULV test , 21 of them underwent testing at 15J . Among these 21 patients, the 15-J vu lnerability test induced VF in 11 patients (ULV > 15J) and (C) d id not induce VF in 10 patients (10J< ULV S15J) But (#2, B) 15-J ULV test could not be done in 5 patients because of their unstable hemodynamics (hypotension or b radycardia) after VF defib rillation.
(#3) The ULV test was started at 15J in the next 47 patients. VF was induced at 15J in 10 patients (2 1 %; ULV > 15 J) and not induced in 37 (79%; ULV SI 5J) . The 1O-J ULV test was done in the 37 patients with ULV :S;15J . VFwas induced at (El 10J ULVin 13 patients (35%; 10J< ULV :S;15J) and VFwas not induced in 24 patients (65%; ULV :S; 10J). Accordingly, in all of the 96 patients, (A ) ULV s 10J was confirmed in 47 patients (49%) and (B-E) ULV >10J was confirmed in 49 patients (5 1%). With regard to the ULV :s; or >15J, it was able to be decided in 9 1 patients. Of these, (A ,C,E) ULV s 15J was confirmed in 70 patients (77%) and (0 ) ULV > 15J was confirmed in 2 1 patients (23%). OFT, defibrillation threshold: PIs , patients; ULV, upper limit of vulnerability; VF, ventricular fi brillation . High OFT defined as >20J
Methods

Patients
The . ubjecL~ con. isted of 96 pat ient s (80 men, 16 women) lIndergoing implantat ion of an )CD/CRTD for the first time (n= 75 ) or as a replacement (n=2 1) between March 2006 and ovember 2008. All palients underwent transthoracic echocardiography and routine laboratory testin g, and all patient. · gave Wli llen infomled consent before the device implantati on.
Device Implantation
Pati enl s were ane. thetized w ith propofo l or mida7olam. Heart rhythm . en saturation. and continuolls sy ·temic blood pressure were moni lored throug ho ut all procedure . . Di. po. able adhesive defibrillator pads were applied 10 (h e patien ts and artac hed (0 the external defibrillator for re cue cardioversion . Yariou. deIlbrillator mode ls were imp lanted. The defibri ll ator . y. tem was insened th rough a left pectoral incision in all pat.ients except for 3 who had a hislOry of device infection (n=) ) and dialy is va!>Cu-lar access (n=2 ). The tip o f the ventricular shock lead was placed at or near the right ventricul ar apex if the R wave was ~ m V and lhe pacing thre ho ld was :S; 1.5 mY al 0 .5 ms. Before defibri llator replacemen t. previously impl<m ted shock leads were confinncd to sali sfy all the afore melllioned cri teria.
Determination of Vulnerable Period
During ri ght ve ntri cu lar paci ng with a cycle length (Cl) of • 500 illS via the shock lead, the l ate~1 peak of the monopha 'ic Twave was determi ned on standard 12-lead electrocardiography (ECG) displayed at I OOmm/s, a nd the illlerva l fro mlhe stimulus to the lalest peak of lhe T-wave (St-T peak inlerval) was measured . A limb-lead ECG was substituted if a 12-lead ECG was unavailable. The vulnerable period was determined from -20 to +20 m. of the latest T peak, as described. rs .!!
Definition of Ventricular Fibrillation
Arrhythmias wi dl CL <280 ms w idl polymorphic and irregular ( Cl >40 ms) QRS complexes on surface ECG were cia sified a YF. An'hythmias with monomorphi c QRS complexe orCL >280 m. were defi ned a. ven tricu lar tachycardia and excl uded from the YF cou nLlJ
Vulnerability and Defibrillation Testing
Vu lnerability testing was started at 10J in the earl y enrolled 49 palie nt (Figure) . The fi rst I OJ T-wave s hock was delivered at the St-T peak interval after 8 right ventricuIar pac ing beats wi th CL=5OO ms. IJ VF was not induced. a sub:-.equent 10-J ~ho{' k was delive red at -20 m. and +20ms to the St-T peak il11erva l. If three 10-J shocks wi th difk rent timing did not induce VF. we determi ned that the UL V wa!> $ IOJ. and then subsequent s hock~ were decreased to 5 or I J. and deli vered ill the same sequence until VF was induced. If VF wa: not induced by a seri e.~ of inductio n shoc ks. VF wa. induced by alternat ive method .. uch as a hi gh frequency b ur~t for defibri llati on test ing.
Vulnerabil ily was tesled at I-mi n intervals bel ween shock .. If VF was induced. defi bri llation wa~ Ie. ted. Five mi nules afte r VF defibrillati on. the energy of th e next LV teo t shock was incrensed to 15 J and de li ered in the ame ma nner. I I' VF was also induced aIlS 1. il was determined th at the UL V wm> > 15 1. If VF wa~ not induced by any 15-J T-wave shock . . the UL V Wa! determined a ' $ 151.
The aim of this !>tudy was to estimate the OFT withoul inducing VF. The fi rst 10-J T-wave shocks. however. ind uced Fi n many pati enL~ (53lk ) usi ng Ih i. pmtocol. -nlerefore. we changed th e firs t ind uction shock to ISJ in the next 47 p<llients (Figure) . The pmtocol for the IS-J shocks wa: the same a~ that de. cribed fo r the 10-J . hocks.
Duri ng defi brillati on te. ting for induced VF. we eval uated onl y whether DFT was $20J or nol. TIle fir ,t defibrillation !>hock was set at 20 J ,md the second was sel at the maximum deli vered energy of each device. If the fiN 20-J . hock cou ld not defib ri 1-late (DFT >20 J). the fi r 'l shock was increa ed by S J unt il VF was defi brillated in sub equ ent ddi brillation tesls. We defi ned DFT a. the sma llesl shock slrength that defibri ll ated Iwice .
In bolh vul nerahility and defibrillation te!'ting. shock energy was unified as de li ve red energy. Therefore. the programmed (charged) energy wa. adjusted to obtai n th e required deli ve red energy for the Gu idanl defi brillator (de livered energy of 10. IS and 20 J wa eq ui valenlto charged energy of II . 17 and 23 J, respecli vely).
If a patient became hemodynamically unstable or fell into VF seve ra lt im~ du ring these tests. vulnerability and defi bri llation TAKAMI Ketal. lesling w~re ~I o pped according 10 Ihe dec i~i o n of Ihe operator.
Statistical Analysis
Base line charac teristic!> are give n a~ mean ± SD and we re analyzed for stati sti ca l significance using pai red t-te t fo r contin uous va riahles and Fisher's exact te!'.t for calegorical variabl es. P<O.OS wa. conside red . tatisti ca ll y . igniflcanl.
Results
Tn i)l(' I li~t s the pat ient characterislics. Ant i-arrhyth mic drugs (am iodaJOne. n= 15 : sotalo!' n= 7: mexi letine. n=2: pirmenoI. n= I: procainamide. n= I) were given to 26 patients and f3-blockers were give n to 70 (73%) at th e time of the procedure .
Device Implantation
Atlhe time of I D implant ation. th e mean R wave amplitu de on the ventricul ar sensing lead was 12.6±5. llmV (range. S.O-29. lmV ). The stimulation thre 'hold was < 1.5 Vat 0.5 nlS in all p atie nL~. Dual-c hamber ICDs and CRTDs were implanted in 73 and IS pati ents. respecti ve ly. No m (~or pe riopemti ve compl iC<l-li o n~ develo ped that required add itiona l procedure!>.
Vulnerable Period
The Illean St-T peak interval W'b 3 SI ±3Sm~. 0 visihle T-wave alteman ' developed al right ventricular pacing al 500 ms CL.
Vulnerability and Defibrillation Testing
The UL V Ie. I wa start ed at 10 J in the early enrolled 49 pati ent. (Figure) . VF was induced at 10 J in 26 patient. Among the 47 patients without VF induction on the IO-J LV te,~t. 39 pati ent~ underwent the S-J UL V t e,~t and VF w~ induced in 28 pati ents (S J< LV $ IOJ). The I-J ULV le. t was done in 19 patients ( II patient · without VF inducti on by the S-J LV test and 8 patie nts who di d not un dergo the S-J LV test) and VF w,c induced in 17 paLients ( 11< ULV ~5 J in 10 pa t ient~ and 11< UL V $ 1 OJ in 7 pati ent ). In the remaining 2 pati ents. hi gh frequ ency burst pacing was required for indu 'ing VF.
UlV and High OFT
In all of the 96 patients. UL V $ 1 OJ wa ' confimled in 47 patients (49o/c; Figure A) and LV > I OJ was confi rmed in 49 patients (Sl lff: Figure R-E) . In tOlal, II pa ti e nL~ ( II o/e) had high DFT (>20 J) and ULV wa~ > 10 J in all of these II patients. In 38 of 49 patie nt.: with ULV > 10J, however, OFT was <20 J (acceptable DFT). The sensiti vity • . peci lk ity. pos itive predicti ve value (PPV ) and negative predicti ve alue( PV )of LV > IOJfor predicting hi gh DFf were 100%. SS %. 22o/ r and 100'7<,. respecli vely (Table 2) .
Becau e 15-J LV test could not be done in S pati ent (Figure B) , the decision ,l~ to whether UL V was $ ISJ or > I SJ Upp The ra te of YF inducibi lity to confi rm LV ::; 15J wa. lower than that for ULV $ IOJ (23% S. 51 0/(', P<O.OOO I).
PV of LV> 15 J for predicting hi gh DFf were I OO~, 85~. 43 % and 100%. respectively (Table 2) .
10-J ULV vs. 15-J ULV Test
A total of 86 patients underwent IO-J ULY test and VF was in· duced in 39 patient!> (45% ; Table ] ). And 68 patiellls underwent 15-J ULV test and VF was induced in 21 patients (3 1%). The 
Optimal Number of Shocks at ULV Test
We del ivered,) 'hocks within the vuln erable period (-20. O. +20 ms to the peak of T-wave wave). The effec ti ve ness of the 15-J UL test wi Lh ~ing le shock only at Lhe peak of Lhe T-wave wa. ana lyzed. VF wa~ induced hy single shock at 15 J in 12 of 68 patients. and a high Off was found in S (42~ ) of th e~e 12 patients. Among S6 patjents without VF induction by the single IS-J ULV test. 4 patients (7. 1 % ) had a hi gh OFT. The sen. itivity. specificity. PPV :lI1d PV of VF inducibility by ~i n g l e 15-J shock forpredicting 'a high OFrwere 55~. 88%, 42~ and 93%, respective ly (Tahle .' ). The . ensiti vity of single 15-J UL V test was con ' iderably lower than that for the 15-J U LV te t with 3 coupling intervals, and the NPV of ~ing l e UL V test was < I 00%.
Defibrillation Testing and High OFT
The ICO immediately . enseu VF in all patient. during defibrillation te~ting. and the R wave was not und er-se n~d during F e\'en when se nsi tivity was sufficie ntl y blunted. Induced F cou ld not be te rminated by a firs t rescue 20-J . hock in I I patients (high OFT). System modification such as repo:irioning of Lhe . hock lead or changi ng of the direction of the sho k wave wa. required in 4 of them to ach ieve an adeq uate OFT safety rna rgi n (OFr Smax imum device output energy-I OJ).
PreVl~e nce of non-ischemic cardiomyopaLh y (P=O.OS). lower left ve ntricular (LV) ejection fraction (P=O.05).larger LV enddia ·tolic and end-systolic di mension (p=0.05 and 0.07, res pectively) were more common in patients wiLh hi gh Off but Lhe TAKAMI K et al.
uitlerence~ did not reac h ~ignifican e (Tahle 5).
Number of Induction Shocks and Procedure Duration
The mean number of indul.:tion T-wave shock. was 5.7±2.3: the total duration of the test was 14.2±2A min and the amount of time required to confinn effective defibri llat ion energy (twice) or acceptable LV (~I Oor S I S .I ) Wa! 6.2±4.7 min for all pati enl~.
Complications
either major compl iealions nor prolonged unstahle hemodynamil.:~ requiring inotropiC age nt s or mechanica l ~uppurt were encoun tt'red in thi s ~e Ji es.
Discussion
The major fi nding ' can be summarized as follows . The UL V test at JO and 15J is a reli able method to identi fy patients wi th ;In acceptable OFT (gOJ). In patients wi th acceptable Or:T, the rate of VF inuucibility by 15-J LV test was signitkantly lower than that for tJ1e 10-J ULV test. Single LV test at the peak of T-wave ~ome tilll es undere. timated the LV . Basel ine patient characteri ti cs could not predict hi gh OFf. but ULV could.
Ba eu on these find ing '. the 15-J L te t with 3 co upling intervals (-20, O. and +20ms to the peak ofT-wave) waS thought to be a re liabl e method to ident ify high-OFT patents wit hout inducing VF.
Previous Reports
To date. a close correlatjon between the LV and OFr at the time of defib rillator implan tation ha~ been re ported l 2-14 These findi ngs suggest that vu lnerahility testing can be safely and reliably suhstituted for conventional defihrill ati on testi ng. Regarding device implantation without induction of VF. Lhe IS-J LV test W~L~ more feas ible compared wiLh Lhe 10-J UL V test. Hwang et al showed th at the ULV Wa! <?OJ in 7S % of 60 pati e nl~. and all of them had OFr <OOJ.24 Swerdlow et al howed that indueti onles implantation i~ feasible in >80% of patient based on vu lnerability testing at 151. 25 111e ASSUR E study compared vulnerabi lit y ale ty margin testing vS. defibrillati on safery margin test wi th a . ing le VF indUl.:tionldefi brillation: T 5 14-J vulnerabi lity testing with 3 coupling intervals was carried out in 420 patient s. VF was not induced in 322 patients (76.70/, ) and defibrillation \Va. achieved wi Lh _ I-J shocks in 3 17 of them (98.4%). Among Lhe 98 patients (23. 3 o/r ) in whom VF was induced at 14-J vulnerabi lity teo ting. 2 1 (2 I A o/r ) had OFT >2 11. The predictive alue of VF inducibility fur detecting hi gh OFr in the present study was comparatively higher than that of ASSURE. The ICO device produced by Guidant Wa! used in Lhe ASS RE study. In the Guidant ICO ~y tem. the programmed energy of 14J i convened in to 12J at ~h ock deliveT)' and tJ1e programmed energy of 2 1 J i convel1ed into 18 J at shock deli very. Vulnerabi lit y test at " 121" in th e ASS RE stud . eems to be a reaso n for lhe relati vely lower pred ictive value of VF inducibility for detectin g high OFT.
Determination of Vulnerable Period and Underestimation of ULV
The vulnerable zone was defined as a combination of coupl ing interval. and the strength of the T-wave shock. It is shown as a 2-0 , diamond-shaped space defi ned by the coupling interval on the absc i'sa and shock strength on th e ordinate. 26 we rdl ow et al inves ti gated the timing of the peak of the human vulnerable zone using ri ght ventricular pacing at a CL of 500ms and ~h owed that the peak of the human vulnerable LOne is narrow lllld includes a median of only two 20-ms intervals . I. ' They re-
Upper Limit of Vulnerability Test ported Ihat a lO-ms difference coul d cause undereslilllaliun of lhe L . and Ihe mo '1 reliable method to define the LV i ' to scan the vulnerable period of the T-wave . hock wirhin a windO\ of 40 m~ (in lO-ms step) before and after the T-wave peak. We delemlincd the vulnerable peliod as a window of 201m before and after the T-wave peak . Although Ih is method might undereSlimme the LV . none of the pat ie nts with either UL V ~JO J or ~15 J hau a hi gh OFf.
A single T-wave . hock unde re,~tim a res the actua l L V in the present study. In the T LIP study vulnerahi lity test was done at a si ngle couplin g inLerval on th e T-wave of lhe ECG lead U.I" Although this simplified method reduced the num ber of req uired induction shocks and the proce-d ure lime. the accuracy of meauring LV mi ght be red uced. A T-wave shock was del ivered after ve ntricular pacing al a CL of 400m~ in the T ULLP study.'6 Must uf the ULV stud ie~ used a hasic CL of 500 ms. Pac ing CL might affect the width of the vulnerable period . Furthermore. a ~horteneu pacing CL mighl cause beal-to-beat in ·tabilit y of repolarization ~uch as T-wave alternans.
Inducibility of VF During Vulnerability Testing
AU the patients in whom VF was nOI induced by UL V te~t at both 10J and 15 J had an acceptahle OFf (<?OJ) . And in aJilhe patient~ wi th hi gh OFf. VF was induced by both 10-J anu 15-J V tes t. The 10-J and 15-J UL V test. huwever. inuuced VF in ~ I and in 12 patient s willl acce pt able OFf. respectively . The higher del ivered energy at ULV teo t Illightlower VF inducibi lity in patients withou t a high OFf. but it might invol ve a ris k or mi .. ing a hig h OFf. Further detai led prospecti ve study to identify the ideal energy at UL V test is required.
Avoidance of VF induction at defibrill ator implantati on i~ req uired in patients wi th severe heart failure. Unfortunatel in these patient ·. VF is likely to be induced even by the vulnerabilit y test. Pati ent. wi th more advanced heart failure were more like ly to have high OFT intlle ASSURE study.'s In cOlllras t. the parameters or cardiac fun cti on 'uch as LV ejection fra cti on and LV dimen~ions did not predict high OFT in the present stud .. but L V could predi ct hi gh OFf. AltllOugh ~ever;11 'lUdies have attempted to identify the predicti ve fa ctors assoc iated with hi gh OFT.27-.11 it has bee n dirficu ltto identify hi gh-OFf patients without vulnerability or defibrillat io n testing.
Study limitations
The pre. ent study had so me I imitat ions. Shock energy other than 10 or 15J might be optimal in vulnerabilit y teo ting. Some patients might have a lowerlimit of vulnerabil ity> I OJ or> 15J. This likelihood. however. seems to be vanishingly smail because none of th e pat ient. without VF induced on 10-J ULV te. ting had hi gh OFT.
WithOllt inducing VF. R-wave sensing during induced VF cannot be ensured. But in patient · with sinus rhythm R·wave sensing amplitude >5 mV. R-wave sensi ng dUling VF Wn! thought to be aim t always reliable. and critical delay in detecting VF wa~ not observed in previous reports. 21 Determination of the vulnerable peri od u. ing 12-lead ECG is e elllial for the UL V test. Thi ' proce require ' ex tra time and adeq uate experience. Recelllly. t.he u sefuln es~ uf automated vulnerability te. t for predicting hi gh OFT hal been repoJ1ed. 21 The vulnerable period that was automati cally ca l ulated by their ' oftware IVa. well correlated wi th the St-T pea k interval. The 18-J vulnerability test at 4 coupling intervals could correctly detect high-OFT patients wi th 19% of VF inducibilit . The automated LV test Illay be able to in crease the utility of the L V t e~t in cl inical practice. 2495 Multiple inducti on shocks mi ght increase OFr. More than 10 multiple induction shocks were sometimes requireti in the presem srudy. I f these induct ion . hocks increased the OFT. OFT might he overestilllated. hut we did not identify a significant dissociatiun between UL V and OFT.
Clinical Implications
At the time of defi hrillator implantation . the 15-J LV te, t wi th 3 coupling illlerva is (-20. O. and +20 ms to the peak of T-wave) was thou ght to be a re li able method to detect high DFf. The vulnerable period ~hou ld be detelmined as -:!O. 0 and +10ms to the St-T peak interval using multi-Ieau ECG during pacing at a CL of 500rns. U' <lily of the 3 T-wave shoc'ks cannot induce VF. no furth er inducti on is req uireu and implantatiun without VF induction C,lIl be completed.
Although the ULV test can de(.' J'Case the necess ity for VF induction. F tend. to be induced by tht: UL V test in patients willl depressed LV functi on, in whom VF indu ction is hoped to be avoided. Accordingly. we ha ve considered the indication of the LV te: t as follows . For the secondary prevemion of . udden cardiac death. UL V test should be done. And . if VF i~ induced. Jefibrillati on safety margin should be ensured. and syslem revision shoulu be done if needed. For primary prevention. the UL V I.e~t mi ght be avoided in patient.~ with . everely depressed LV functi on. ImpoJ1antly, the neces. it y of ULV t e~t ~h o uld be decided on a patient-by-pati ent basis.
Conclusion
The L test at 10 and 15J witld coupling il1lervals (-10. O. and +20ms to the peak ofT-wave) is a reliable method to identify pati e nt~ with an acceptable OFT (~20J ). Baseline patient charaCleri stics did not predict high-OFT patient s. but ULV could detect high·OFf patients. For t.he purpo 'e of defibrilla tor implantation without inducing VF, the 15-J LV test was more fea~ible th an the I O-J te~t.
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